26 May 2013
Keywords: negative, trial, results, rock, immunex, enbrel, dropped
Article | 23 March 2001
Immunex has decided not to continue with its Phase II/III trials programfor Enbrel (etanercept) as a treatment for chronic ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.